• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

核 Smad6 通过负调控 PIAS3 介导的 STAT3 抑制促进神经胶质瘤发生。

Nuclear Smad6 promotes gliomagenesis by negatively regulating PIAS3-mediated STAT3 inhibition.

机构信息

Center of Clinical Research, Wuxi People's Hospital of Nanjing Medical University, Wuxi, Jiangsu, 214023, China.

Department of Neurosurgery, Wuxi People's Hospital of Nanjing Medical University, Wuxi, Jiangsu, 214023, China.

出版信息

Nat Commun. 2018 Jun 27;9(1):2504. doi: 10.1038/s41467-018-04936-9.

DOI:10.1038/s41467-018-04936-9
PMID:29950561
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6021382/
Abstract

To date, the molecular mechanism underlying constitutive signal transducer and activator of transcription 3 (STAT3) activation in gliomas is largely unclear. In this study, we report that Smad6 is overexpressed in nuclei of glioma cells, which correlates with poor patient survival and regulates STAT3 activity via negatively regulating the Protein Inhibitors of Activated STAT3 (PIAS3). Mechanically, Smad6 interacts directly with PIAS3, and this interaction is mediated through the Mad homology 2 (MH2) domain of Smad6 and the Ring domain of PIAS3. Smad6 recruits Smurf1 to facilitate PIAS3 ubiquitination and degradation, which also depends on the MH2 domain and the PY motif of Smad6. Consequently, Smad6 reduces PIAS3-mediated STAT3 inhibition and promotes glioma cell growth and stem-like cell initiation. Moreover, the Smad6 MH2 transducible protein restores PIAS3 expression and subsequently reduces gliomagenesis. Collectively, we conclude that nuclear-Smad6 enhances glioma development by inducing PIAS3 degradation and subsequent STAT3 activity upregulation.

摘要

迄今为止,胶质瘤中组成性信号转导和转录激活因子 3(STAT3)激活的分子机制在很大程度上尚不清楚。在这项研究中,我们报告了 Smad6 在神经胶质瘤细胞核中过表达,这与患者预后不良相关,并通过负调控激活 STAT3 的蛋白抑制剂(PIAS3)来调节 STAT3 活性。在机制上,Smad6 直接与 PIAS3 相互作用,这种相互作用是通过 Smad6 的 Mad 同源结构域 2(MH2)和 PIAS3 的环结构域介导的。Smad6 招募 Smurf1 促进 PIAS3 的泛素化和降解,这也依赖于 Smad6 的 MH2 结构域和 PY 基序。因此,Smad6 减少了 PIAS3 介导的 STAT3 抑制作用,促进了神经胶质瘤细胞的生长和干细胞样细胞的起始。此外,Smad6 的 MH2 转导蛋白恢复了 PIAS3 的表达,随后降低了神经胶质瘤的发生。综上所述,核 Smad6 通过诱导 PIAS3 降解和随后的 STAT3 活性上调,增强了神经胶质瘤的发展。

相似文献

1
Nuclear Smad6 promotes gliomagenesis by negatively regulating PIAS3-mediated STAT3 inhibition.核 Smad6 通过负调控 PIAS3 介导的 STAT3 抑制促进神经胶质瘤发生。
Nat Commun. 2018 Jun 27;9(1):2504. doi: 10.1038/s41467-018-04936-9.
2
TRIM8 modulates STAT3 activity through negative regulation of PIAS3.TRIM8 通过负向调节 PIAS3 来调节 STAT3 的活性。
J Cell Sci. 2010 Jul 1;123(Pt 13):2238-45. doi: 10.1242/jcs.068981. Epub 2010 Jun 1.
3
TRIM8 regulates stemness in glioblastoma through PIAS3-STAT3.TRIM8通过PIAS3-STAT3调节胶质母细胞瘤的干性。
Mol Oncol. 2017 Mar;11(3):280-294. doi: 10.1002/1878-0261.12034. Epub 2017 Feb 15.
4
PIAS3-mediated feedback loops promote chronic colitis-associated malignant transformation.PIAS3 介导的反馈环促进慢性结肠炎相关的恶性转化。
Theranostics. 2018 Apr 30;8(11):3022-3037. doi: 10.7150/thno.23046. eCollection 2018.
5
The intracellular delivery of a recombinant peptide derived from the acidic domain of PIAS3 inhibits STAT3 transactivation and induces tumor cell death.细胞内递送源自 PIAS3 酸性结构域的重组肽抑制 STAT3 反式激活并诱导肿瘤细胞死亡。
Mol Cancer Res. 2010 Apr;8(4):539-53. doi: 10.1158/1541-7786.MCR-09-0417. Epub 2010 Apr 6.
6
Cooperative interaction between protein inhibitor of activated signal transducer and activator of transcription-3 with epidermal growth factor receptor blockade in lung cancer.活化信号转导子与转录激活子3的蛋白抑制剂与肺癌中表皮生长因子受体阻断之间的协同相互作用
Int J Cancer. 2009 Oct 1;125(7):1728-34. doi: 10.1002/ijc.24553.
7
SHP2, SOCS3 and PIAS3 Expression Patterns in Medulloblastomas: Relevance to STAT3 Activation and Resveratrol-Suppressed STAT3 Signaling.髓母细胞瘤中SHP2、SOCS3和PIAS3的表达模式:与STAT3激活及白藜芦醇抑制的STAT3信号传导的相关性
Nutrients. 2016 Dec 27;9(1):3. doi: 10.3390/nu9010003.
8
Ascochlorin, an isoprenoid antibiotic inhibits growth and invasion of hepatocellular carcinoma by targeting STAT3 signaling cascade through the induction of PIAS3.阿斯科氯素,一种类异戊二烯抗生素,通过诱导PIAS3靶向信号转导和转录激活因子3(STAT3)信号级联反应,抑制肝细胞癌的生长和侵袭。
Mol Oncol. 2015 Apr;9(4):818-33. doi: 10.1016/j.molonc.2014.12.008. Epub 2015 Jan 5.
9
PIAS3, SHP2 and SOCS3 Expression patterns in Cervical Cancers: Relevance with activation and resveratrol-caused inactivation of STAT3 signaling.PIAS3、SHP2和SOCS3在宫颈癌中的表达模式:与STAT3信号通路的激活及白藜芦醇诱导的失活的相关性
Gynecol Oncol. 2015 Dec;139(3):529-35. doi: 10.1016/j.ygyno.2015.09.087. Epub 2015 Oct 4.
10
The association and nuclear translocation of the PIAS3-STAT3 complex is ligand and time dependent.PIAS3-STAT3 复合物的关联和核易位与配体和时间有关。
Mol Cancer Res. 2009 Nov;7(11):1854-60. doi: 10.1158/1541-7786.MCR-09-0313. Epub 2009 Nov 10.

引用本文的文献

1
STAT signaling pathways in immune cells and their associated mechanisms in cancer pathogenesis.免疫细胞中的STAT信号通路及其在癌症发病机制中的相关机制。
Bioimpacts. 2024 May 11;15:30030. doi: 10.34172/bi.30030. eCollection 2025.
2
Hantaan virus glycoprotein Gc induces NEDD4-dependent PTEN ubiquitination and degradation to escape the restriction of autophagosomes and facilitate viral propagation.汉坦病毒糖蛋白Gc诱导NEDD4依赖的PTEN泛素化和降解,以逃避自噬体的限制并促进病毒传播。
FASEB J. 2025 Jan 15;39(1):e70295. doi: 10.1096/fj.202401916R.
3
Smad1 Promotes Tumorigenicity and Chemoresistance of Glioblastoma by Sequestering p300 From p53.

本文引用的文献

1
The PIAS3-Smurf2 sumoylation pathway suppresses breast cancer organoid invasiveness.PIAS3-Smurf2 类泛素化修饰途径抑制乳腺癌类器官的侵袭性。
Oncotarget. 2017 Mar 28;8(13):21001-21014. doi: 10.18632/oncotarget.15471.
2
Nur77 suppresses hepatocellular carcinoma via switching glucose metabolism toward gluconeogenesis through attenuating phosphoenolpyruvate carboxykinase sumoylation.Nur77 通过抑制磷酸烯醇式丙酮酸羧激酶的 sumoylation 来将葡萄糖代谢转向糖异生,从而抑制肝癌。
Nat Commun. 2017 Feb 27;8:14420. doi: 10.1038/ncomms14420.
3
Smad6 determines BMP-regulated invasive behaviour of breast cancer cells in a zebrafish xenograft model.
Smad1通过从p53中隔离p300促进胶质母细胞瘤的致瘤性和化疗耐药性。
Adv Sci (Weinh). 2025 Jan;12(4):e2402258. doi: 10.1002/advs.202402258. Epub 2024 Dec 4.
4
A review on potential heterocycles for the treatment of glioblastoma targeting receptor tyrosine kinases.关于针对受体酪氨酸激酶的治疗胶质母细胞瘤的潜在杂环的综述。
Oncol Res. 2024 Apr 23;32(5):849-875. doi: 10.32604/or.2024.047042. eCollection 2024.
5
PIAS family in cancer: from basic mechanisms to clinical applications.癌症中的PIAS家族:从基本机制到临床应用
Front Oncol. 2024 Mar 25;14:1376633. doi: 10.3389/fonc.2024.1376633. eCollection 2024.
6
p53/E2F7 axis promotes temozolomide chemoresistance in glioblastoma multiforme.p53/E2F7 轴促进多形性胶质母细胞瘤对替莫唑胺的化疗耐药性。
BMC Cancer. 2024 Mar 7;24(1):317. doi: 10.1186/s12885-024-12017-y.
7
Global research trends in immunotherapy for glioma: a comprehensive visualization and bibliometric analysis.全球胶质母细胞瘤免疫治疗研究趋势:全面可视化和文献计量分析。
Front Endocrinol (Lausanne). 2023 Oct 5;14:1273634. doi: 10.3389/fendo.2023.1273634. eCollection 2023.
8
The SUMOylation and ubiquitination crosstalk in cancer.癌症中的类泛素化修饰与泛素化修饰之间的相互作用
J Cancer Res Clin Oncol. 2023 Nov;149(17):16123-16146. doi: 10.1007/s00432-023-05310-z. Epub 2023 Aug 28.
9
Acetylation halts missense mutant p53 aggregation and rescues tumor suppression in non-small cell lung cancers.乙酰化作用可阻止错义突变型p53聚集,并挽救非小细胞肺癌中的肿瘤抑制作用。
iScience. 2023 May 30;26(7):107003. doi: 10.1016/j.isci.2023.107003. eCollection 2023 Jul 21.
10
Characterization of EGFR-reprogrammable temozolomide-resistant cells in a model of glioblastoma.胶质母细胞瘤模型中表皮生长因子受体(EGFR)可重编程的替莫唑胺耐药细胞的特征分析
Cell Death Discov. 2022 Oct 31;8(1):438. doi: 10.1038/s41420-022-01230-y.
在斑马鱼异种移植模型中,Smad6决定了骨形态发生蛋白(BMP)调节的乳腺癌细胞侵袭行为。
Sci Rep. 2016 Apr 26;6:24968. doi: 10.1038/srep24968.
4
Immunotherapy for cancer in the central nervous system: Current and future directions.中枢神经系统癌症的免疫疗法:现状与未来方向
Oncoimmunology. 2015 Sep 11;5(2):e1082027. doi: 10.1080/2162402X.2015.1082027. eCollection 2016 Feb.
5
The ubiquitin ligase Smurf2 suppresses TGFβ-induced epithelial-mesenchymal transition in a sumoylation-regulated manner.泛素连接酶Smurf2以一种SUMO化修饰调控的方式抑制TGFβ诱导的上皮-间质转化。
Cell Death Differ. 2016 May;23(5):876-88. doi: 10.1038/cdd.2015.152. Epub 2015 Dec 18.
6
The SUMO (Small Ubiquitin-like Modifier) Ligase PIAS3 Primes ATR for Checkpoint Activation.小泛素样修饰物(SUMO)连接酶PIAS3使ATR启动检查点激活。
J Biol Chem. 2016 Jan 1;291(1):279-90. doi: 10.1074/jbc.M115.691170. Epub 2015 Nov 12.
7
STAT3 the oncogene - still eluding therapy?致癌基因STAT3——仍未找到治疗方法?
FEBS J. 2015 Jul;282(14):2600-11. doi: 10.1111/febs.13285. Epub 2015 Apr 22.
8
Inhibition of lethal inflammatory responses through the targeting of membrane-associated Toll-like receptor 4 signaling complexes with a Smad6-derived peptide.通过使用源自Smad6的肽靶向膜相关Toll样受体4信号复合物来抑制致死性炎症反应。
EMBO Mol Med. 2015 May;7(5):577-92. doi: 10.15252/emmm.201404653.
9
Modification of DBC1 by SUMO2/3 is crucial for p53-mediated apoptosis in response to DNA damage.SUMO2/3 对 DBC1 的修饰对于 p53 介导的 DNA 损伤应答诱导的细胞凋亡至关重要。
Nat Commun. 2014 Nov 18;5:5483. doi: 10.1038/ncomms6483.
10
RRAD promotes EGFR-mediated STAT3 activation and induces temozolomide resistance of malignant glioblastoma.RRAD 促进 EGFR 介导的 STAT3 激活,并诱导恶性脑胶质瘤对替莫唑胺的耐药性。
Mol Cancer Ther. 2014 Dec;13(12):3049-61. doi: 10.1158/1535-7163.MCT-14-0244. Epub 2014 Oct 13.